The Last Round Against Bacterial Infections?

Overview

Journal Infection

Date 1990 Jul 1

PMID 2210849

Authors

W Marget

Affiliations

Soon will be listed here.

References

Mar P, Marget W, Schneider K, Belohradsky B, Roos R . Relevance of vesico-ureteric reflux in development of lipid A antibodies in recurrent urinary tract infections in children--a preliminary study. Eur J Pediatr. 1987; 146(1):51-5. DOI: 10.1007/BF00647284. View

Westphal O . Bacterial endotoxins. The second Carl Prausnitz Memorial Lecture. Int Arch Allergy Appl Immunol. 1975; 49(1-2):1-43. View

Marget W, Mar P, Jaspers L, Possinger K, Haslberger H . Preliminary study on administration of high-titer lipid A antibody serum in sepsis and septic shock patients. Infection. 1985; 13(3):120-4. DOI: 10.1007/BF01642870. View

Jaspers L, Marget W, Mar P, Hoffmann K, Langecker P, Ruckdeschel G . [Antibody to lipoid A in the treatment of septic shock]. Infection. 1987; 15 Suppl 2:S89-95. DOI: 10.1007/BF01644200. View

Bogard Jr W, Dunn D, Abernethy K, Kilgarriff C, Kung P . Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity. Infect Immun. 1987; 55(4):899-908. PMC: 260436. DOI: 10.1128/iai.55.4.899-908.1987. View

Teng N, Kaplan H, Hebert J, Moore C, Douglas H, Wunderlich A . Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A. 1985; 82(6):1790-4. PMC: 397358. DOI: 10.1073/pnas.82.6.1790. View

Ziegler E, McCutchan J, Fierer J, Glauser M, Sadoff J, Douglas H . Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982; 307(20):1225-30. DOI: 10.1056/NEJM198211113072001. View

Marget W, Schussler P . Letter: Lipopolysaccharides in Crohn's disease. Lancet. 1976; 2(7976):97. DOI: 10.1016/s0140-6736(76)92314-x. View

Rietschel E, Kim Y, Watson D, Galanos C, LUDERITZ O, Westphal O . Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun. 1973; 8(2):173-7. PMC: 422829. DOI: 10.1128/iai.8.2.173-177.1973. View

10.

Simon G, Reindke B, Marget W . [Lipid A antibody titers in pyelonephritis and other gram-negative infections (author's transl)]. Infection. 1974; 2(4):178-84. DOI: 10.1007/BF01641457. View

11.

Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

12.

Marget W . [Lipoid A antibody titer in humans]. Infection. 1987; 15 Suppl 2:S85-8. DOI: 10.1007/BF01644199. View

13.

Galanos C, LUDERITZ O, Westphal O . Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides. Eur J Biochem. 1971; 24(1):116-22. DOI: 10.1111/j.1432-1033.1971.tb19661.x. View